BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 15223333)

  • 1. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development.
    Cowan CA; Yokoyama N; Saxena A; Chumley MJ; Silvany RE; Baker LA; Srivastava D; Henkemeyer M
    Dev Biol; 2004 Jul; 271(2):263-71. PubMed ID: 15223333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells.
    Hamada K; Oike Y; Ito Y; Maekawa H; Miyata K; Shimomura T; Suda T
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):190-7. PubMed ID: 12588758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
    Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of signaling interactions and receptor endocytosis in growing blood vessels.
    Pitulescu ME; Adams RH
    Cell Adh Migr; 2014; 8(4):366-77. PubMed ID: 25482636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
    Bai J; Wang YJ; Liu L; Zhao YL
    J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bidirectional signaling mediated by ephrin-B2 and EphB2 controls urorectal development.
    Dravis C; Yokoyama N; Chumley MJ; Cowan CA; Silvany RE; Shay J; Baker LA; Henkemeyer M
    Dev Biol; 2004 Jul; 271(2):272-90. PubMed ID: 15223334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent Roles of Ephrin-B2/EphB4 Guidance System in Pulmonary Hypertension.
    Crnkovic S; Rittchen S; Jandl K; Gindlhuber J; Zabini D; Mutgan AC; Valzano F; Boehm PM; Hoetzenecker K; Toller W; Veith C; Heinemann A; Schermuly RT; Olschewski A; Marsh LM; Kwapiszewska G
    Hypertension; 2023 Feb; 80(2):e17-e28. PubMed ID: 36519465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis.
    Helbling PM; Saulnier DM; Brändli AW
    Development; 2000 Jan; 127(2):269-78. PubMed ID: 10603345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural crest defects in ephrin-B2 mutant mice are non-autonomous and originate from defects in the vasculature.
    Lewis AE; Hwa J; Wang R; Soriano P; Bush JO
    Dev Biol; 2015 Oct; 406(2):186-95. PubMed ID: 26385750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration.
    Adams RH; Diella F; Hennig S; Helmbacher F; Deutsch U; Klein R
    Cell; 2001 Jan; 104(1):57-69. PubMed ID: 11163240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
    Füller T; Korff T; Kilian A; Dandekar G; Augustin HG
    J Cell Sci; 2003 Jun; 116(Pt 12):2461-70. PubMed ID: 12734395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forward signaling by EphB1/EphB2 interacting with ephrin-B ligands at the optic chiasm is required to form the ipsilateral projection.
    Chenaux G; Henkemeyer M
    Eur J Neurosci; 2011 Nov; 34(10):1620-33. PubMed ID: 22103419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand.
    Rutkowski R; Mertens-Walker I; Lisle JE; Herington AC; Stephenson SA
    Int J Cancer; 2012 Sep; 131(5):E614-24. PubMed ID: 22161689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
    Wang Y; Nakayama M; Pitulescu ME; Schmidt TS; Bochenek ML; Sakakibara A; Adams S; Davy A; Deutsch U; Lüthi U; Barberis A; Benjamin LE; Mäkinen T; Nobes CD; Adams RH
    Nature; 2010 May; 465(7297):483-6. PubMed ID: 20445537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.
    Du E; Li X; He S; Li X; He S
    Mol Biol Rep; 2020 Jun; 47(6):4681-4690. PubMed ID: 32488576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development.
    Gerety SS; Wang HU; Chen ZF; Anderson DJ
    Mol Cell; 1999 Sep; 4(3):403-14. PubMed ID: 10518221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of embryonic gene expression defines potential interaction sites for Xenopus EphB4 receptors with ephrin-B ligands.
    Helbling PM; Saulnier DM; Robinson V; Christiansen JH; Wilkinson DG; Brändli AW
    Dev Dyn; 1999 Dec; 216(4-5):361-73. PubMed ID: 10633856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of transgenic mice overexpressing EfnB2 in endothelial cells.
    Luxey M; Laussu J; Jungas T; Davy A
    Genesis; 2011 Oct; 49(10):811-20. PubMed ID: 21735541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2-EphB4 Signaling in Melanoma Metastatic Spine Disease.
    Piffko A; Broggini T; Harms C; Adams RH; Vajkoczy P; Czabanka M
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis.
    Kim YH; Hu H; Guevara-Gallardo S; Lam MT; Fong SY; Wang RA
    Development; 2008 Nov; 135(22):3755-64. PubMed ID: 18952909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.